Trellis Rx Honored on Inc. 5000 List for Second Consecutive Year as One of the Nation’s Fastest-Growing Private Companies

 Achievement caps a banner year for the company and health system specialty pharmacy growth ATLANTA–(BUSINESS WIRE)–#healthsystems—Trellis Rx, LLC, a leading health system specialty pharmacy services provider now part of the CPS Solutions, LLC, family of companies, has been named to the prestigious Inc. 5000 list for the second consecutive year, ranking #754. The recognition, which … [Read more…]

Paragonix Technologies Celebrates Clinical Milestone of over 2,000 Organs Preserved and Transported for Transplantation

Now over 1 in 5 Thoracic Organ Transplants are preserved using Paragonix Advanced Organ Preservation and Tracking Technology CAMBRIDGE, Mass.–(BUSINESS WIRE)–Paragonix Technologies, Inc. is announcing a major milestone of preserving over 2,000 donor organs, providing transplant centers Advanced Organ Preservation (AOPT) technology and a nationwide clinical support network. Each of these technologies utilize first-of-its-kind preservation … [Read more…]

Restore Hyper Wellness Announces First Half of 2022 Performance Results with Over $60M in System-Wide Sales & Official Announcement of its Medical Advisory Board

System-Wide Sales Up 84% YoY, Delivered One Million Wellness Services and Introduces Medical Advisory Board as it Continues Exponential Growth AUSTIN, Texas–(BUSINESS WIRE)–Restore Hyper Wellness (Restore), the leading provider of proactive wellness services, announced its business performance results for the first half of 2022, with system-wide sales surpassing $60 million, an increase of 84% year-over-year. … [Read more…]

Atomwise Signs Strategic Multi-Target Research Collaboration with Sanofi for AI-Powered Drug Discovery

Agreement includes upfront payment of $20 million with the potential for $1 billion in milestone-based payments plus tiered royalties SAN FRANCISCO–(BUSINESS WIRE)–#AI–Atomwise, a leader in using artificial intelligence (AI) for small molecule drug discovery, today announced that it has established a strategic and exclusive research collaboration with Sanofi that will leverage its AtomNet® platform for … [Read more…]

XLerateHealth, University of Kentucky to Expand Entrepreneurship & Commercialization Programming via Digital Learning Platform

Selected for National Institute of Health (NIH) I-RED Award to expand support for academic innovation, translation, and commercialization LOUISVILLE, Ky.–(BUSINESS WIRE)–XLerateHealth (XLH), a national healthcare accelerator based in Louisville, KY, in partnership with the University of Kentucky (UK) through UK Innovate, has been awarded the first phase of a potential $3.25M multi-year grant by the … [Read more…]

PerkinElmer Announces Finance Leadership Transition

Max Krakowiak appointed new chief financial officer, replacing Jamey Mock WALTHAM, Mass.–(BUSINESS WIRE)–PerkinElmer, Inc. (NYSE:PKI), a global leader committed to innovating for a healthier world, today announced that Senior Vice President and Chief Financial Officer Jamey Mock will be transitioning from the Company to pursue an outside opportunity. The Company’s Board of Directors has unanimously … [Read more…]

Mytide Therapeutics Partners with Agilent to Collaborate on Automation Solutions for Mytide’s Next-generation Manufacturing Platform

Agilent will supply analytical and preparative chromatography equipment for Mytide’s discovery and personalized therapeutics technology platform. Agreement aligns with Mytide’s focus on bringing together technology companies to address automation, reliability and data quality issues across the peptide industry. BOSTON–(BUSINESS WIRE)–Mytide Therapeutics, a company transforming peptide manufacturing with predictive analytics and machine learning, has partnered with … [Read more…]

Cybin and Clinilabs Granted Schedule I DEA License for CYB003 Phase 1/2a First-In-Human Clinical Trial

TORONTO–(BUSINESS WIRE)–Cybin Inc. (NEO:CYBN) (NYSE American:CYBN) (“Cybin” or the “Company”), a biopharmaceutical company focused on progressing “Psychedelics to Therapeutics™”, and its partner Clinilabs Drug Development Corporation (“Clinilabs”), a global, full-service contract research organization with deep expertise in central nervous system drug development, today announced that the U.S. Drug Enforcement Agency (“DEA”) has granted a Schedule … [Read more…]

Axonics® Expands Sacral Neuromodulation Intellectual Property Portfolio

IRVINE, Calif.–(BUSINESS WIRE)–Axonics, Inc. (Nasdaq: AXNX), a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, today announced that in the last twelve months, the United States Patent and Trademark Office has granted eight patents and allowed four patent applications related to the company’s sacral … [Read more…]

More than half of American parents report negative impacts of the pandemic on their children

LifeWorks Mental Health IndexTM reveals managers and young employees are most likely to feel tension or conflict at work CHICAGO–(BUSINESS WIRE)–LifeWorks, a leading provider of digital and in-person total wellbeing solutions, today released its monthly Mental Health IndexTM revealing 51 percent of Americans report negative impacts on their children due to the events over the … [Read more…]